Nanjing Kingsun Imp & Exp Co., Ltd.

Depuis 2022Plus
Type d'Entreprise:Manufacturer/Factory, Trading Company
Capacité de R&D:OEM, ODM, Own Brand
Produits Principaux:Disposable Medical, Epidural Kit, Anesthesia Needle, Epidural Catheter, Foley Catheter, Infusion Pump, Biopsy Needle, Bone Marrow Needle, Centre Venous Catheter Kit, Drainage Bottle
{"app": "App", "root": "#root", "props": "#ssrData", "options": {"type":"react","main":false,"router":"none","base":"","path":"","csr":false}}

Company Overview

Nanjing Kingsun Imp & Exp Co., Ltd. is a professional manufacturer specializing in R&D, manufacture and sales of disposable medical. With a production site in Touqiao Town, Yangzhou City-One of the largest medical consumables production bases in China.

Our business scope include various disposable medical, such as anesthesia kit, epidural kit, anesthesia needle, epidural needle, spinal needle, infusion pump, biopsy needle, bone marrow needle, blood collecting tube etc...

As of 2023, we have delivered products to customers from over 100 countries in multiple regions such as the European Union, the Middle East, Southeast Asia, and Africa, and have gained high recognition from our users.

Since founded, Kingsun sure quality decides everything and we always look the services is our company′ S life. We persist in the tenet of "Quality First, Excellent Service, Observe Reputation". Sincerely wish to cooperate with friends from both at home and abroad, we will committed to providing customers with the best products and services.

Member Info

Manufacturer/Factory,Trading Company
Health & Medicine,Security & Protection
ISO 13485,FSC

Trade Information

FOB, EXW, CFR, CIF
LC, T/T, D/P
Peak season lead time: one month
Off season lead time: within 15 workdays

Export Information

2022-03-31
>90%
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe
Have Own Export License

Production Capacity

Tongda Road, Touqiao Town ,Yangzhou City ,Jiangsu ,China
OEM, ODM, Own Brand()
5-10 People
Above 10
Above US$100 Million